Cochrane · systematic review · CD011919
Resveratrol for adults with type 2 diabetes mellitus
Jeyaraman, MM, Al‐Yousif, NSH, Singh Mann, A, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library
Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
4
No studies
3
Included studies
NR
No studies 3 · 42.9%Ungraded 0 · 0%Very low 4 · 57.1%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings for resveratrol plus oral anti‐diabetic drugs versus placebo plus oral anti‐diabetic drugs
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Diabetes‐related complications Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs | no estimate extracted | NR | No studies |
All‐cause mortality Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs | no estimate extracted | 3 studies · 50 participants | Very low Downgraded: imprecision, indirectness |
Diabetes‐related mortality Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs | no estimate extracted | 3 studies · 50 participants | Very low Downgraded: imprecision, indirectness |
Health‐related quality of life Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs | no estimate extracted | NR | No studies |
Adverse events Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs | no estimate extracted | 3 studies · 50 participants | Very low Downgraded: imprecision, indirectness |
HbA1c (%) Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs | no estimate extracted | 2 studies · 31 participants | Very low Downgraded: imprecision, indirectness |
Socioeconomic effects Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs | no estimate extracted | NR | No studies |